nodes	percent_of_prediction	percent_of_DWPC	metapath
Meclizine—CYP1A2—Flutamide—prostate cancer	0.229	0.347	CbGbCtD
Meclizine—CYP1A2—Estrone—prostate cancer	0.165	0.251	CbGbCtD
Meclizine—CYP1A2—Conjugated Estrogens—prostate cancer	0.108	0.164	CbGbCtD
Meclizine—CYP1A2—Estradiol—prostate cancer	0.0949	0.144	CbGbCtD
Meclizine—CYP1A2—Etoposide—prostate cancer	0.062	0.0941	CbGbCtD
Meclizine—Drowsiness—Flutamide—prostate cancer	0.00471	0.0322	CcSEcCtD
Meclizine—Cyclizine—SULT1E1—prostate cancer	0.00386	0.241	CrCbGaD
Meclizine—Anaphylactic shock—Estrone—prostate cancer	0.00325	0.0222	CcSEcCtD
Meclizine—Anaphylactoid reaction—Conjugated Estrogens—prostate cancer	0.00316	0.0216	CcSEcCtD
Meclizine—Vision blurred—Degarelix—prostate cancer	0.00311	0.0213	CcSEcCtD
Meclizine—Dry mouth—Nilutamide—prostate cancer	0.00308	0.0211	CcSEcCtD
Meclizine—Fatigue—Abiraterone—prostate cancer	0.00285	0.0195	CcSEcCtD
Meclizine—Anaphylactic shock—Estradiol valerate/Dienogest—prostate cancer	0.00284	0.0194	CcSEcCtD
Meclizine—Dry mouth—Degarelix—prostate cancer	0.00275	0.0188	CcSEcCtD
Meclizine—Anaphylactic shock—Degarelix—prostate cancer	0.0027	0.0185	CcSEcCtD
Meclizine—Somnolence—Flutamide—prostate cancer	0.00267	0.0183	CcSEcCtD
Meclizine—Dry mouth—Cabazitaxel—prostate cancer	0.00259	0.0177	CcSEcCtD
Meclizine—Fatigue—Flutamide—prostate cancer	0.00259	0.0177	CcSEcCtD
Meclizine—Anaphylactoid reaction—Estradiol—prostate cancer	0.00253	0.0173	CcSEcCtD
Meclizine—Fatigue—Estradiol valerate/Dienogest—prostate cancer	0.00245	0.0167	CcSEcCtD
Meclizine—Drowsiness—Goserelin—prostate cancer	0.00238	0.0163	CcSEcCtD
Meclizine—Asthenia—Abiraterone—prostate cancer	0.00237	0.0162	CcSEcCtD
Meclizine—Anaphylactoid reaction—Mitoxantrone—prostate cancer	0.00235	0.0161	CcSEcCtD
Meclizine—Fatigue—Degarelix—prostate cancer	0.00232	0.0159	CcSEcCtD
Meclizine—Dry mouth—Bicalutamide—prostate cancer	0.00222	0.0152	CcSEcCtD
Meclizine—Fatigue—Cabazitaxel—prostate cancer	0.00219	0.015	CcSEcCtD
Meclizine—Asthenia—Nilutamide—prostate cancer	0.00217	0.0148	CcSEcCtD
Meclizine—Asthenia—Flutamide—prostate cancer	0.00216	0.0148	CcSEcCtD
Meclizine—Headache—Estramustine—prostate cancer	0.00213	0.0146	CcSEcCtD
Meclizine—Headache—Estrone—prostate cancer	0.00204	0.0139	CcSEcCtD
Meclizine—Asthenia—Estradiol valerate/Dienogest—prostate cancer	0.00204	0.0139	CcSEcCtD
Meclizine—Anaphylactoid reaction—Etoposide—prostate cancer	0.00196	0.0134	CcSEcCtD
Meclizine—Somnolence—Bicalutamide—prostate cancer	0.00194	0.0133	CcSEcCtD
Meclizine—Asthenia—Degarelix—prostate cancer	0.00193	0.0132	CcSEcCtD
Meclizine—Headache—Nilutamide—prostate cancer	0.00189	0.0129	CcSEcCtD
Meclizine—Headache—Flutamide—prostate cancer	0.00188	0.0129	CcSEcCtD
Meclizine—Fatigue—Bicalutamide—prostate cancer	0.00188	0.0129	CcSEcCtD
Meclizine—Asthenia—Cabazitaxel—prostate cancer	0.00182	0.0125	CcSEcCtD
Meclizine—Headache—Estradiol valerate/Dienogest—prostate cancer	0.00178	0.0122	CcSEcCtD
Meclizine—Drowsiness—Mitoxantrone—prostate cancer	0.00176	0.012	CcSEcCtD
Meclizine—Vision blurred—Goserelin—prostate cancer	0.00175	0.012	CcSEcCtD
Meclizine—Vision blurred—Conjugated Estrogens—prostate cancer	0.00173	0.0119	CcSEcCtD
Meclizine—Headache—Degarelix—prostate cancer	0.00169	0.0116	CcSEcCtD
Meclizine—Headache—Cabazitaxel—prostate cancer	0.00159	0.0109	CcSEcCtD
Meclizine—Fatigue—Ethinyl Estradiol—prostate cancer	0.00159	0.0109	CcSEcCtD
Meclizine—Asthenia—Bicalutamide—prostate cancer	0.00156	0.0107	CcSEcCtD
Meclizine—Dry mouth—Goserelin—prostate cancer	0.00155	0.0106	CcSEcCtD
Meclizine—Anaphylactic shock—Goserelin—prostate cancer	0.00152	0.0104	CcSEcCtD
Meclizine—Anaphylactic shock—Conjugated Estrogens—prostate cancer	0.0015	0.0103	CcSEcCtD
Meclizine—Headache—Bicalutamide—prostate cancer	0.00137	0.00934	CcSEcCtD
Meclizine—Somnolence—Goserelin—prostate cancer	0.00135	0.00922	CcSEcCtD
Meclizine—Somnolence—Conjugated Estrogens—prostate cancer	0.00133	0.00914	CcSEcCtD
Meclizine—Imatinib—PDGFRB—prostate cancer	0.00133	0.0835	CrCbGaD
Meclizine—Asthenia—Ethinyl Estradiol—prostate cancer	0.00132	0.00904	CcSEcCtD
Meclizine—Fatigue—Goserelin—prostate cancer	0.00131	0.00894	CcSEcCtD
Meclizine—Bifonazole—CYP17A1—prostate cancer	0.0013	0.0816	CrCbGaD
Meclizine—Fatigue—Conjugated Estrogens—prostate cancer	0.00129	0.00886	CcSEcCtD
Meclizine—Vision blurred—Mitoxantrone—prostate cancer	0.00129	0.00885	CcSEcCtD
Meclizine—Dry mouth—Estradiol—prostate cancer	0.00123	0.00839	CcSEcCtD
Meclizine—Anaphylactic shock—Estradiol—prostate cancer	0.0012	0.00822	CcSEcCtD
Meclizine—Headache—Ethinyl Estradiol—prostate cancer	0.00115	0.0079	CcSEcCtD
Meclizine—Anaphylactic shock—Mitoxantrone—prostate cancer	0.00112	0.00766	CcSEcCtD
Meclizine—Anaphylactoid reaction—Epirubicin—prostate cancer	0.0011	0.00751	CcSEcCtD
Meclizine—Asthenia—Goserelin—prostate cancer	0.00109	0.00744	CcSEcCtD
Meclizine—Asthenia—Conjugated Estrogens—prostate cancer	0.00108	0.00737	CcSEcCtD
Meclizine—Somnolence—Estradiol—prostate cancer	0.00107	0.00731	CcSEcCtD
Meclizine—Fatigue—Estradiol—prostate cancer	0.00104	0.00709	CcSEcCtD
Meclizine—Anaphylactoid reaction—Doxorubicin—prostate cancer	0.00102	0.00695	CcSEcCtD
Meclizine—Somnolence—Mitoxantrone—prostate cancer	0.000995	0.00681	CcSEcCtD
Meclizine—Fatigue—Mitoxantrone—prostate cancer	0.000965	0.00661	CcSEcCtD
Meclizine—Headache—Goserelin—prostate cancer	0.00095	0.0065	CcSEcCtD
Meclizine—Headache—Conjugated Estrogens—prostate cancer	0.000941	0.00644	CcSEcCtD
Meclizine—Anaphylactic shock—Etoposide—prostate cancer	0.000931	0.00637	CcSEcCtD
Meclizine—Vision blurred—Capecitabine—prostate cancer	0.000865	0.00592	CcSEcCtD
Meclizine—Asthenia—Estradiol—prostate cancer	0.000862	0.0059	CcSEcCtD
Meclizine—Somnolence—Etoposide—prostate cancer	0.000828	0.00567	CcSEcCtD
Meclizine—Drowsiness—Epirubicin—prostate cancer	0.000819	0.0056	CcSEcCtD
Meclizine—Asthenia—Mitoxantrone—prostate cancer	0.000803	0.0055	CcSEcCtD
Meclizine—Fatigue—Etoposide—prostate cancer	0.000803	0.0055	CcSEcCtD
Meclizine—Dry mouth—Docetaxel—prostate cancer	0.00079	0.0054	CcSEcCtD
Meclizine—Anaphylactic shock—Docetaxel—prostate cancer	0.000774	0.0053	CcSEcCtD
Meclizine—Vision blurred—Prednisone—prostate cancer	0.000771	0.00528	CcSEcCtD
Meclizine—Dry mouth—Capecitabine—prostate cancer	0.000765	0.00523	CcSEcCtD
Meclizine—Drowsiness—Doxorubicin—prostate cancer	0.000757	0.00518	CcSEcCtD
Meclizine—Imatinib—SLC22A1—prostate cancer	0.000756	0.0473	CrCbGaD
Meclizine—Headache—Estradiol—prostate cancer	0.000753	0.00515	CcSEcCtD
Meclizine—Headache—Mitoxantrone—prostate cancer	0.000702	0.0048	CcSEcCtD
Meclizine—Somnolence—Docetaxel—prostate cancer	0.000688	0.00471	CcSEcCtD
Meclizine—Asthenia—Etoposide—prostate cancer	0.000668	0.00457	CcSEcCtD
Meclizine—Anaphylactic shock—Prednisone—prostate cancer	0.000668	0.00457	CcSEcCtD
Meclizine—Fatigue—Docetaxel—prostate cancer	0.000667	0.00457	CcSEcCtD
Meclizine—Bifonazole—CYP19A1—prostate cancer	0.000663	0.0415	CrCbGaD
Meclizine—Fatigue—Capecitabine—prostate cancer	0.000646	0.00442	CcSEcCtD
Meclizine—Imatinib—CYP3A5—prostate cancer	0.00061	0.0382	CrCbGaD
Meclizine—Vision blurred—Epirubicin—prostate cancer	0.000603	0.00413	CcSEcCtD
Meclizine—Azelastine—CYP3A5—prostate cancer	0.000592	0.037	CrCbGaD
Meclizine—Headache—Etoposide—prostate cancer	0.000584	0.00399	CcSEcCtD
Meclizine—Fatigue—Prednisone—prostate cancer	0.000576	0.00394	CcSEcCtD
Meclizine—Azelastine—CYP2A6—prostate cancer	0.000573	0.0358	CrCbGaD
Meclizine—Flunarizine—CYP2A6—prostate cancer	0.00056	0.035	CrCbGaD
Meclizine—Vision blurred—Doxorubicin—prostate cancer	0.000558	0.00382	CcSEcCtD
Meclizine—Asthenia—Docetaxel—prostate cancer	0.000555	0.0038	CcSEcCtD
Meclizine—Asthenia—Capecitabine—prostate cancer	0.000538	0.00368	CcSEcCtD
Meclizine—Dry mouth—Epirubicin—prostate cancer	0.000533	0.00365	CcSEcCtD
Meclizine—Nefazodone—CYP3A5—prostate cancer	0.000531	0.0332	CrCbGaD
Meclizine—Anaphylactic shock—Epirubicin—prostate cancer	0.000522	0.00357	CcSEcCtD
Meclizine—Bifonazole—CYP2E1—prostate cancer	0.000495	0.0309	CrCbGaD
Meclizine—Dry mouth—Doxorubicin—prostate cancer	0.000493	0.00337	CcSEcCtD
Meclizine—Bifonazole—CYP2C19—prostate cancer	0.00049	0.0306	CrCbGaD
Meclizine—Headache—Docetaxel—prostate cancer	0.000485	0.00332	CcSEcCtD
Meclizine—Anaphylactic shock—Doxorubicin—prostate cancer	0.000483	0.00331	CcSEcCtD
Meclizine—Asthenia—Prednisone—prostate cancer	0.000479	0.00328	CcSEcCtD
Meclizine—Headache—Capecitabine—prostate cancer	0.00047	0.00321	CcSEcCtD
Meclizine—Somnolence—Epirubicin—prostate cancer	0.000464	0.00318	CcSEcCtD
Meclizine—Fatigue—Epirubicin—prostate cancer	0.00045	0.00308	CcSEcCtD
Meclizine—Cinnarizine—CYP2A6—prostate cancer	0.000443	0.0277	CrCbGaD
Meclizine—Somnolence—Doxorubicin—prostate cancer	0.000429	0.00294	CcSEcCtD
Meclizine—Headache—Prednisone—prostate cancer	0.000418	0.00286	CcSEcCtD
Meclizine—Fatigue—Doxorubicin—prostate cancer	0.000417	0.00285	CcSEcCtD
Meclizine—Imatinib—CYP2C19—prostate cancer	0.000415	0.026	CrCbGaD
Meclizine—Azelastine—CYP2E1—prostate cancer	0.000407	0.0254	CrCbGaD
Meclizine—Azelastine—CYP2C19—prostate cancer	0.000403	0.0252	CrCbGaD
Meclizine—Azelastine—CYP1A1—prostate cancer	0.000401	0.0251	CrCbGaD
Meclizine—Flunarizine—CYP1A1—prostate cancer	0.000392	0.0246	CrCbGaD
Meclizine—Asthenia—Epirubicin—prostate cancer	0.000375	0.00256	CcSEcCtD
Meclizine—Asthenia—Doxorubicin—prostate cancer	0.000347	0.00237	CcSEcCtD
Meclizine—Headache—Epirubicin—prostate cancer	0.000327	0.00224	CcSEcCtD
Meclizine—Bifonazole—CYP3A4—prostate cancer	0.000312	0.0195	CrCbGaD
Meclizine—Cinnarizine—CYP1A1—prostate cancer	0.00031	0.0194	CrCbGaD
Meclizine—Headache—Doxorubicin—prostate cancer	0.000303	0.00207	CcSEcCtD
Meclizine—Imatinib—CYP3A4—prostate cancer	0.000264	0.0165	CrCbGaD
Meclizine—Azelastine—CYP3A4—prostate cancer	0.000256	0.016	CrCbGaD
Meclizine—Nefazodone—CYP3A4—prostate cancer	0.00023	0.0144	CrCbGaD
Meclizine—Loperamide—CYP3A4—prostate cancer	0.000193	0.0121	CrCbGaD
Meclizine—Prochlorperazine—CYP3A4—prostate cancer	0.00019	0.0119	CrCbGaD
Meclizine—CYP1A2—Metabolism—CKMT2—prostate cancer	7.67e-05	0.000428	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—UGT2B15—prostate cancer	7.67e-05	0.000428	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—GRHPR—prostate cancer	7.67e-05	0.000428	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—PPP3CA—prostate cancer	7.62e-05	0.000425	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—CXCL12—prostate cancer	7.56e-05	0.000422	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—ANXA1—prostate cancer	7.51e-05	0.000419	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	7.5e-05	0.000419	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—MED12—prostate cancer	7.38e-05	0.000412	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PENK—prostate cancer	7.32e-05	0.000409	CbGpPWpGaD
Meclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	7.28e-05	0.000407	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—AOX1—prostate cancer	7.21e-05	0.000403	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—PGAM2—prostate cancer	7.21e-05	0.000403	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—SULT2B1—prostate cancer	7.21e-05	0.000403	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—NAGLU—prostate cancer	7.21e-05	0.000403	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—MBTPS1—prostate cancer	7.21e-05	0.000403	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—GSTM3—prostate cancer	7.21e-05	0.000403	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—RFK—prostate cancer	7.21e-05	0.000403	CbGpPWpGaD
Meclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—prostate cancer	7.19e-05	0.000401	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	7.05e-05	0.000394	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—CALCA—prostate cancer	7.03e-05	0.000393	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—GHR—prostate cancer	6.98e-05	0.00039	CbGpPWpGaD
Meclizine—HRH1—G alpha (q) signalling events—PIK3CA—prostate cancer	6.98e-05	0.000389	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—PRKCQ—prostate cancer	6.9e-05	0.000385	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—CXCL12—prostate cancer	6.87e-05	0.000383	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CYP3A43—prostate cancer	6.84e-05	0.000382	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—AMACR—prostate cancer	6.84e-05	0.000382	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—NAT1—prostate cancer	6.84e-05	0.000382	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—SRD5A2—prostate cancer	6.84e-05	0.000382	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—DEGS1—prostate cancer	6.84e-05	0.000382	CbGpPWpGaD
Meclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—prostate cancer	6.79e-05	0.000379	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	6.73e-05	0.000376	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—NRP1—prostate cancer	6.7e-05	0.000374	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	6.68e-05	0.000373	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—HSD17B1—prostate cancer	6.52e-05	0.000364	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	6.52e-05	0.000364	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—ADRB2—prostate cancer	6.49e-05	0.000362	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—VAV3—prostate cancer	6.33e-05	0.000353	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	6.27e-05	0.00035	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—PRKCQ—prostate cancer	6.27e-05	0.00035	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	6.24e-05	0.000348	CbGpPWpGaD
Meclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—prostate cancer	6.24e-05	0.000348	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—GNRH1—prostate cancer	6.23e-05	0.000348	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—VIP—prostate cancer	6.23e-05	0.000348	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	6.18e-05	0.000345	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—ITPR1—prostate cancer	6.14e-05	0.000343	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—LPAR1—prostate cancer	6.03e-05	0.000337	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—GRP—prostate cancer	6.03e-05	0.000337	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PLCB2—prostate cancer	5.97e-05	0.000333	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—LRP2—prostate cancer	5.97e-05	0.000333	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—ADRB2—prostate cancer	5.89e-05	0.000329	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	5.88e-05	0.000329	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—P4HB—prostate cancer	5.85e-05	0.000327	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CX3CL1—prostate cancer	5.85e-05	0.000327	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—HPGD—prostate cancer	5.81e-05	0.000325	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—B4GALT4—prostate cancer	5.81e-05	0.000325	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—VAV3—prostate cancer	5.75e-05	0.000321	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—HIST1H2BG—prostate cancer	5.75e-05	0.000321	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—GRB7—prostate cancer	5.69e-05	0.000318	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PDE4D—prostate cancer	5.69e-05	0.000318	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—ITPR1—prostate cancer	5.57e-05	0.000311	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—HIST1H4H—prostate cancer	5.55e-05	0.00031	CbGpPWpGaD
Meclizine—HRH1—GPCR ligand binding—CXCL8—prostate cancer	5.55e-05	0.00031	CbGpPWpGaD
Meclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—prostate cancer	5.52e-05	0.000308	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—TNFRSF21—prostate cancer	5.47e-05	0.000305	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—GNG5—prostate cancer	5.42e-05	0.000302	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CYP7B1—prostate cancer	5.32e-05	0.000297	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—MTAP—prostate cancer	5.32e-05	0.000297	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	5.2e-05	0.00029	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—SULT1E1—prostate cancer	5.18e-05	0.000289	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—SRD5A1—prostate cancer	5.18e-05	0.000289	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	5.03e-05	0.000281	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	4.96e-05	0.000277	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—HSD17B3—prostate cancer	4.94e-05	0.000276	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—ACSL4—prostate cancer	4.94e-05	0.000276	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	4.89e-05	0.000273	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—ARG2—prostate cancer	4.74e-05	0.000265	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—PHGDH—prostate cancer	4.74e-05	0.000265	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—UMPS—prostate cancer	4.74e-05	0.000265	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—TGFBR1—prostate cancer	4.72e-05	0.000263	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PTHLH—prostate cancer	4.72e-05	0.000263	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	4.72e-05	0.000263	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—LDHB—prostate cancer	4.65e-05	0.00026	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—AKR1C3—prostate cancer	4.64e-05	0.000259	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PRKACB—prostate cancer	4.62e-05	0.000258	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CYP3A5—prostate cancer	4.56e-05	0.000255	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PPP3CA—prostate cancer	4.5e-05	0.000251	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—THBS1—prostate cancer	4.5e-05	0.000251	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—ANXA1—prostate cancer	4.44e-05	0.000248	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—PDHA1—prostate cancer	4.41e-05	0.000246	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—TCN2—prostate cancer	4.41e-05	0.000246	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—UCP3—prostate cancer	4.41e-05	0.000246	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—GSTA3—prostate cancer	4.41e-05	0.000246	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PRKCZ—prostate cancer	4.35e-05	0.000243	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—PIK3CG—prostate cancer	4.26e-05	0.000238	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—FGFR4—prostate cancer	4.21e-05	0.000235	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PARP1—prostate cancer	4.21e-05	0.000235	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—SLC22A3—prostate cancer	4.2e-05	0.000235	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—HSD3B1—prostate cancer	4.2e-05	0.000235	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CALCA—prostate cancer	4.15e-05	0.000232	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—prostate cancer	4.08e-05	0.000228	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CXCL12—prostate cancer	4.06e-05	0.000227	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—TBXAS1—prostate cancer	4.03e-05	0.000225	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—GSTA4—prostate cancer	4.03e-05	0.000225	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	3.94e-05	0.00022	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—GSTA2—prostate cancer	3.93e-05	0.000219	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—ABCG5—prostate cancer	3.88e-05	0.000217	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—SULT1A1—prostate cancer	3.88e-05	0.000217	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—PIK3CG—prostate cancer	3.86e-05	0.000216	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CASP9—prostate cancer	3.82e-05	0.000213	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—GSTA1—prostate cancer	3.79e-05	0.000212	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—HSD3B2—prostate cancer	3.75e-05	0.000209	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—NAT2—prostate cancer	3.75e-05	0.000209	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—GSTO1—prostate cancer	3.75e-05	0.000209	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—PIK3CD—prostate cancer	3.74e-05	0.000209	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PRKCQ—prostate cancer	3.7e-05	0.000207	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—NGFR—prostate cancer	3.7e-05	0.000207	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—MAP3K7—prostate cancer	3.66e-05	0.000204	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	3.6e-05	0.000201	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—PLCB2—prostate cancer	3.59e-05	0.000201	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—LRP2—prostate cancer	3.59e-05	0.000201	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CYP2C18—prostate cancer	3.59e-05	0.000201	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—P4HB—prostate cancer	3.52e-05	0.000197	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—FGF10—prostate cancer	3.52e-05	0.000196	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—ADRB2—prostate cancer	3.48e-05	0.000194	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—JAK2—prostate cancer	3.43e-05	0.000192	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—SLC22A1—prostate cancer	3.43e-05	0.000191	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—MAP2K1—prostate cancer	3.42e-05	0.000191	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—PIK3CD—prostate cancer	3.4e-05	0.00019	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—VAV3—prostate cancer	3.39e-05	0.000189	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	3.39e-05	0.000189	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—TGFBR2—prostate cancer	3.35e-05	0.000187	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—SULT2A1—prostate cancer	3.34e-05	0.000186	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—ITPR1—prostate cancer	3.29e-05	0.000184	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—MED12—prostate cancer	3.29e-05	0.000183	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—PIK3CB—prostate cancer	3.26e-05	0.000182	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—GNG5—prostate cancer	3.26e-05	0.000182	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—IGF1R—prostate cancer	3.15e-05	0.000176	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—NCOA3—prostate cancer	3.14e-05	0.000175	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—CXCL8—prostate cancer	3.13e-05	0.000175	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—JAK2—prostate cancer	3.12e-05	0.000174	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	3.09e-05	0.000172	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—LPL—prostate cancer	3.02e-05	0.000168	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—HPGDS—prostate cancer	3e-05	0.000167	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—IL2—prostate cancer	2.99e-05	0.000167	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PDGFRB—prostate cancer	2.99e-05	0.000167	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CYP2C19—prostate cancer	2.98e-05	0.000166	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—PIK3CB—prostate cancer	2.96e-05	0.000165	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—ITGB3—prostate cancer	2.91e-05	0.000163	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—GSTT1—prostate cancer	2.91e-05	0.000162	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—ACHE—prostate cancer	2.91e-05	0.000162	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CYP2A6—prostate cancer	2.87e-05	0.00016	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	2.86e-05	0.00016	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—CXCL8—prostate cancer	2.85e-05	0.000159	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—ERBB3—prostate cancer	2.83e-05	0.000158	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—FGFR2—prostate cancer	2.82e-05	0.000158	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—AKR1C3—prostate cancer	2.79e-05	0.000156	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—PRKACB—prostate cancer	2.78e-05	0.000155	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CYP17A1—prostate cancer	2.75e-05	0.000154	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—IL2—prostate cancer	2.72e-05	0.000152	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.71e-05	0.000151	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—TERT—prostate cancer	2.71e-05	0.000151	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—NCOA2—prostate cancer	2.62e-05	0.000146	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—HIF1A—prostate cancer	2.59e-05	0.000145	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—LEP—prostate cancer	2.53e-05	0.000141	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CAV1—prostate cancer	2.51e-05	0.00014	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—SLC5A5—prostate cancer	2.5e-05	0.00014	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—KDR—prostate cancer	2.48e-05	0.000138	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CYP2E1—prostate cancer	2.44e-05	0.000136	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—ESR1—prostate cancer	2.42e-05	0.000135	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—NQO1—prostate cancer	2.41e-05	0.000135	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—TH—prostate cancer	2.38e-05	0.000133	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.36e-05	0.000132	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—BAD—prostate cancer	2.36e-05	0.000132	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CYP3A4—prostate cancer	2.35e-05	0.000131	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.34e-05	0.000131	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CYP1B1—prostate cancer	2.31e-05	0.000129	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—APC—prostate cancer	2.28e-05	0.000127	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PIK3CG—prostate cancer	2.28e-05	0.000127	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—EGF—prostate cancer	2.26e-05	0.000126	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—IRS1—prostate cancer	2.26e-05	0.000126	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—GGT1—prostate cancer	2.24e-05	0.000125	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—NCOA1—prostate cancer	2.21e-05	0.000123	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—GSK3B—prostate cancer	2.19e-05	0.000122	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CYP19A1—prostate cancer	2.18e-05	0.000122	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—INS—prostate cancer	2.16e-05	0.000121	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CREBBP—prostate cancer	2.12e-05	0.000118	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—RXRA—prostate cancer	2.1e-05	0.000117	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—IGF1—prostate cancer	2.09e-05	0.000117	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—EGFR—prostate cancer	2.08e-05	0.000116	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.04e-05	0.000114	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—COMT—prostate cancer	2.02e-05	0.000113	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—MAP2K1—prostate cancer	2.02e-05	0.000113	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—GSTP1—prostate cancer	2.01e-05	0.000112	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PIK3CD—prostate cancer	2.01e-05	0.000112	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—PIK3CA—prostate cancer	1.99e-05	0.000111	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—SERPINE1—prostate cancer	1.99e-05	0.000111	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—ITPR1—prostate cancer	1.98e-05	0.000111	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—KRAS—prostate cancer	1.96e-05	0.00011	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.95e-05	0.000109	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—FGF2—prostate cancer	1.92e-05	0.000107	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—NOS3—prostate cancer	1.9e-05	0.000106	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—TYMS—prostate cancer	1.87e-05	0.000105	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—GSTM1—prostate cancer	1.85e-05	0.000103	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—JAK2—prostate cancer	1.84e-05	0.000103	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—LPL—prostate cancer	1.82e-05	0.000101	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—PIK3CA—prostate cancer	1.81e-05	0.000101	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—MDM2—prostate cancer	1.8e-05	0.0001	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—ERBB2—prostate cancer	1.77e-05	9.9e-05	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CYP1A1—prostate cancer	1.75e-05	9.79e-05	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PIK3CB—prostate cancer	1.75e-05	9.77e-05	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—ERCC2—prostate cancer	1.74e-05	9.71e-05	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CXCL8—prostate cancer	1.68e-05	9.39e-05	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CDKN1B—prostate cancer	1.64e-05	9.17e-05	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—MTHFR—prostate cancer	1.64e-05	9.13e-05	CbGpPWpGaD
Meclizine—HRH1—GPCR downstream signaling—AKT1—prostate cancer	1.62e-05	9.07e-05	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CASP3—prostate cancer	1.61e-05	8.98e-05	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—IL2—prostate cancer	1.61e-05	8.97e-05	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—PPARA—prostate cancer	1.6e-05	8.96e-05	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—IL6—prostate cancer	1.6e-05	8.92e-05	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CCND1—prostate cancer	1.57e-05	8.74e-05	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CTNNB1—prostate cancer	1.55e-05	8.66e-05	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—MMP9—prostate cancer	1.52e-05	8.49e-05	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—CDKN1A—prostate cancer	1.52e-05	8.46e-05	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PTEN—prostate cancer	1.51e-05	8.44e-05	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CAV1—prostate cancer	1.51e-05	8.42e-05	CbGpPWpGaD
Meclizine—HRH1—Signaling by GPCR—AKT1—prostate cancer	1.47e-05	8.23e-05	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—EP300—prostate cancer	1.44e-05	8.05e-05	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.44e-05	8.05e-05	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—SRC—prostate cancer	1.4e-05	7.83e-05	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.37e-05	7.67e-05	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—VEGFA—prostate cancer	1.37e-05	7.62e-05	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—STAT3—prostate cancer	1.35e-05	7.55e-05	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—INS—prostate cancer	1.3e-05	7.26e-05	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—CREBBP—prostate cancer	1.27e-05	7.11e-05	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—MYC—prostate cancer	1.26e-05	7.01e-05	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—TGFB1—prostate cancer	1.25e-05	7e-05	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—EGFR—prostate cancer	1.23e-05	6.86e-05	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.21e-05	6.74e-05	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—KRAS—prostate cancer	1.16e-05	6.48e-05	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—NOS3—prostate cancer	1.14e-05	6.37e-05	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—PIK3CA—prostate cancer	1.07e-05	5.95e-05	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.05e-05	5.88e-05	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—PTGS2—prostate cancer	1.04e-05	5.82e-05	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—TP53—prostate cancer	1.03e-05	5.76e-05	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—IL6—prostate cancer	9.44e-06	5.27e-05	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—PTEN—prostate cancer	9.1e-06	5.08e-05	CbGpPWpGaD
Meclizine—HRH1—Signaling Pathways—AKT1—prostate cancer	8.71e-06	4.86e-05	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—EP300—prostate cancer	8.68e-06	4.84e-05	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—PIK3CA—prostate cancer	6.42e-06	3.58e-05	CbGpPWpGaD
Meclizine—CYP1A2—Metabolism—AKT1—prostate cancer	5.24e-06	2.93e-05	CbGpPWpGaD
